World Veterinary Cancer Congress 2016 Foz do Iguassu, Brazil, vinblastine

New insights in dose-escalation of vinblastine in dogs with biologically aggressive mast cell tumours

Manuel Vega-Sillero1, Pedro M. Penedo2, Vitaliy Sobchuk2, Johan P. de Vos1.

Lees meer

World Veterinary Cancer Congress 2016 Foz do Iguassu, Brazil

L-asparaginase activity and plasma amino acid profile in healthy cats after a single injection of PEG-L-asparaginase or native E. Coli L-asparaginase: a pilot study with potential therapeutic consequences

Ada Krupa1, Hubertus Prinsen2, Birgit Schiebergen-Bronkhorst2, Nanda Verhoeven-Duif2, Veerle Mondelaers3, Tim Lammens3, Johan de Vos1

Lees meer

Southern European Veterinary Conference, Barcelona, 15 – 17 October 2015

NEW INSIGHTS IN DOSE-ESCALATION OF VINBLASTINE IN DOGS WITH BIOLOGICALLY AGGRESSIVE MAST CELL TUMOURS

 

Manuel Vega-Sillero, Johan de Vos. 

Abstract ESVONC Krakov 2015

Toceranib phosphate treatment of dogs with head and neck squamous cell carcinoma

 

Adriana Krupa1, Johan de Vos2, Imke Schoepper3, Martin Kessler3, Sue Murphy1

Lees meer

Abstract FECAVA congress Munich 6-9 November 2014

THE EVALUATION OF PROGRESSION FREE SURVIVAL WITH MASITINIB INCORPORATION INTO FIRST LINE AND RESCUE TREATMENT PROTOCOLS IN 147 DOGS WITH MAST CELL NEOPLASIA

 

Johan de Vos1, Gerry Polton2, Francesca Solmi3 & Ada Krupa1

 

Lees meer

Abstract ECVIM congress Mainz 4-6 September 2014

Retrospective analysis of masitinib-based treatment of subcutaneous mast cell tumours in 25 chemo naïve dogs

 

Ada Krupa1, Johan de Vos1, Gerry Polton2

Lees meer

Abstract 10th World Congress of Genetics Applied to Livestock Production, 17-22 August 2014, Vancouver (Canada)

Indications for presence of a major gene for thyroid cancer in German Longhaired Pointers

 

E. H. van der Waaij1, R. P. M. A. Crooijmans1, R. I. Keesler2, A. de Jong1, and J.P. de Vos3.

 

Lees meer

Abstract ESVONC Congress Vienna (Austria) 22-24 May 2014 5

Abstract ESVONC Congress Vienna (Austria) 22-24 May 2014

 

Response to toceranib in dogs with measurable, unresectable, recurrent or metastatic mammary carcinomas

 

Lees meer

Abstract ESVONC Congress Vienna (Austria) 22-24 May 2014 4

Results of PEG-L-asparaginase (Oncaspar®) incorporation in a modified COP-protocol, or added to prednisolone, for the treatment of high-grade lymphoma in cats

 

Ada Krupa1, Erik Teske2, Jetty Maltha1, Paula Hendriks1, Evert van Garderen3 and Johan de Vos1.

Lees meer

Abstract ESVONC Congress Vienna (Austria) 22-24 May 2014 3

A European multicentre pilot study to evaluate the combination of toceranib, lomustine and prednisolone for non-resectable or recurrent canine mast cell tumours

 

Spela Bavcar1, Johan de Vos2, Martin Kessler3, Pauline de Fornel4, Paolo Buracco5, David J. Argyle1

Lees meer

Abstract ESVONC Congress Vienna (Austria) 22-24 May 2014 2

Progression Free Survival of dogs with high-grade T-cell lymphoma, treated with L-CHOP or CCNU-L-CHOP-based protocols as first-line therapy

 

Malgorzata Ossowska1, Maurice Zandvliet2, Lotte Beirens-van Kuijk1, Erik Teske2 en Johan de Vos1

 

Lees meer

Abstract ESVONC Congress Vienna (Austria) 22-24 May 2014

The evaluation of Progression Free Survival with masitinib incorporation into first line and rescue treatment protocols in 147 dogs with mast cell neoplasia

 

Gerry Polton1, Johan de Vos2, Francesca Solmi3, Ada Krupa2

Lees meer

Abstract VCS Conference Minneapolis (USA) 17-19 October 2013

Results of the incorporation of polyethylene-glycol-L-asparaginase (Oncaspar®) in a COP-protocol for the treatment of high grade lymphoma in cats

 

Ada Krupa1, Erik Teske2, Jetty Maltha1, Paula Hendriks1 and Johan de Vos1.

Lees meer

Abstract ESVONC Congress Lisbon 30th May - 1st June 2013

Lymphoma in Dutch and Belgian Dogues de Bordeaux: subtypes and evaluation of the survival time of L-CHOP versus CCNU-L-CHOP treatment in the T-cell subtype

L. Beirens-van Kuijk1, H. De Cock2, E. Teske3, A. Roos1, S. Maes4, R. Fleis-Keesler5, E. Van Garderen6, and J.P. de Vos1.

Lees meer

Poster presentation 25th Annual Symposium of ESVN and ECVN, Ghent 13 - 15 Sept 2012

LYSOSOMAL STORAGE DISEASE IN A PORTUGUESE PODENGO MEDIO

S. Van Meervenne1, J. de Vos2, K. Chiers3, B. San Millan4, C. Navarro4.

Lees meer

Abstract World Veterinary Cancer Congress Parijs 1 - 3 March 2012

Familial nonmedullary thyroid carcinoma in the German Pointer longhair.

 

Johan de Vos1, Liesbeth van der Waaij2

Lees meer

Abstract World Veterinary Cancer Congress Paris 1-3 March 2012

Lomustine induced renal toxicity in dogs: a retrospective study with a prospective follow-up

 

Spela Bavcar1, Arno Roos2, Johan de Vos1

Lees meer

Abstract ESVONC congres Glasgow 2011

First-line and rescue therapy with masitinib integrated protocols for canine cutaneous mast cell tumours.

 

Johan de Vos1 and Malcolm Brearley2.

Lees meer

Abstract VCS Mid-Year congres Las Vegas 2010

Targeted therapy with masitinib in canine and feline tumours in two European veterinary oncology centres.

 

Johan P. de Vos1 and Malcolm J. Brearley2.

 

Lees meer

Abstract VCS congres San Diego 2010 2

First-line and rescue therapy with masitinib integrated protocols for canine cutaneous mast cell tumors.

 

Johan de Vos1 and Malcolm Brearley2.

Lees meer

Abstract VCS congres San Diego 2010

Peri-articular histiocytic sarcoma and synovial cell sarcoma in Bernese Mountain Dogs: a retrospective investigation of the prevalence of these tumors in association with previously diseased joints.

 

L. van Kuijk1, K. van Ginkel2, M. Brearley3, J. Butinar4, I. Gielen5, K. Chiers7, S. Maes7, E. van Garderen6, P.S. Verhoeven2 and J.P. de Vos1

Lees meer

Abstract ESVONC congres Turijn 2010

Peri-articular histiocytic sarcoma in Bernese Mountain Dogs: a retrospective investigation of the prevalence of this tumour in association with previously diseased joints.

 

L. van Kuijk1, K. van Ginkel2, J.P. de Vos1, M. Brearley3, J. Butinar4, I. Gielen5, E. van Garderen6, and P.S. Verhoeven2.

Lees meer

Abstract VCS congres Austin 2009

Response to treatment with masitinib of chemotherapy resistant, metastasized, canine cutaneous grade 2 and 3 mast cell tumors: a pilot study.

 

J.P. de Vos1, P. Dubreuil2, A. Moussy3, T. Chapuis3, A. Burm1, L. van Kuijk1, O. Hermine4.

Lees meer

Abstract ESVONC congres Budapest 2009

Assessment of response to the treatment with masitinib (MASIVET®) of chemotherapy resistant, grade 2 and 3, metastasized canine cutaneous mast cell tumours: report of four cases.

 

J.P. de Vos1, A. Moussy2, A. Burm1, L. van Kuijk1, O. Hermine2.

Lees meer

Abstract VCS Congress Huntington Beach 2005

VINBLASTINE DOSE ESCALATION IN A VINBLASTINE-PREDNISOLON PROTOCOL FOR TREATMENT OF MAST CELL TUMOURS IN DOGS.

 

JP de Vos, AP Focker, AGD Burm, SAE Van Meervenne. De Ottenhorst, Clinic for Companion Animal Medicine, Terneuzen, The Netherlands.

Lees meer

VCS congres Kansas City 2004

RESULTS OF THE COMBINED TREATMENT WITH PIROXICAM AND CARBOPLATIN IN CANINE ORAL NON-TONSILLAR SQUAMOUS CELL CARCINOMA.

 

JP de Vos, AGD Burm, BP Focker, H Boschloo, M Karsijns.

Lees meer

ECVIM congres Barcelona september 2004

RESULTS FROM THE TREATMENT OF CANINE ORAL NON-TONSILLAR SQUAMOUS CELL CARCINOMA WITH PIROXICAM AND CARBOPLATIN.

 

J.P de Vos1, A.G.D. Burm1, B.P. Focker1, H. Boschloo2, M. Karsijns2.

 

Lees meer

Abstract ESVONC Congress februari 2004 in Hofheim

Preliminary results from the treatment of advanced stage squamous cell carcinoma of the nasal planum in cats, using a combination of intralesional carboplatin and superficial radiotherapy.

 

Johan de Vos , Annette Burm en Bram Focker.

 

Lees meer

Openingstijden

Behandeling uitsluitend volgens afspraak. Gedurende de openingstijden kunt u zonder afspraak terecht voor het halen van voeding, medicijnen en hulpmiddelen.

Locatie de Ottenhorst
ma t/m vrij 8.00 - 19.30 uur (behandeling volgens afspraak)
zat 11.00 - 13.00 uur (behandeling volgens afspraak)

Locatie de Steenberghe

Met ingang van 1 juli 2018 gesloten (meer info)


NIEUW! vanaf 12 juni AniPlan®
 

Weekenddienst (spoedgevallen)

10-11 november Dierenziekenhuis Zeeuws-Vlaanderen

17-18 november Dierenkliniek Axel

24-25 november Dierenkliniek de Ark

1-2 december Dierenkliniek Axel

schrijf je in voor de nieuwsbrief